Peter McNamara's most recent trade in Tectonic Therapeutic Inc. was a trade of 6,047 Common Stock done at an average price of $30 . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 06 Mar 2026 | 6,047 | 55,500 | - | 30 | 181,410 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 06 Mar 2026 | 2,500 | 61,332 | - | 2.4 | 5,950 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 2,500 | 31,959 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 215 | 8,045 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 06 Mar 2026 | 215 | 55,285 | - | 35 | 7,525 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.71 per share. | 06 Mar 2026 | 215 | 61,547 | - | 14.7 | 3,163 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 23,000 | 60,482 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 21,000 | 21,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 03 Mar 2026 | 1,650 | 58,832 | - | 25 | 41,250 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.06 per share. | 03 Mar 2026 | 1,649 | 37,482 | - | 22.1 | 36,377 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.22 per share. | 04 Feb 2026 | 1,748 | 39,131 | - | 23.2 | 40,589 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 22 Dec 2025 | 7,000 | 40,879 | - | 3.0 | 20,860 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 7,000 | 25,065 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 8,260 | 8,260 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 4,550 | 33,879 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 27,530 | 27,530 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 15,141 | 29,329 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 3,500 | 34,459 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 03 Dec 2024 | 3,500 | 14,188 | - | 2.4 | 8,330 | Common Stock |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 77,000 | 77,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 37,959 | 37,959 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,065 | 32,065 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,704 | 18,704 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Peter McNamara | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 10,688 | 10,688 | - | - | Common Stock |